Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stock and Flow of Haemodialysis Patients Australia

Published byÁgata Ágatha Benke Modified over 5 years ago

Similar presentations

Presentation on theme: "Stock and Flow of Haemodialysis Patients Australia"— Presentation transcript:

1 Stock and Flow of Haemodialysis Patients Australia 2003 - 2007
Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 7536 Patients

2 Stock and Flow of Haemodialysis Patients New Zealand 2003 - 2007
Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1323 Patients

3 Age of New Haemodialysis Patients 2007
Australia No. Pats

4 Age of Current Haemodialysis Patients
Australia 31-Dec-2007 No. Pats

5 Age of New Haemodialysis Patients 2007
New Zealand No. Pats

6 Age of Current Haemodialysis Patients
New Zealand 31-Dec-2007 No. Pats

7 Distribution of Blood Flow Rates
Number of Patients Australia

8 Distribution of Blood Flow Rates
Number of Patients New Zealand

9 Haemodialysis Frequency (Per Week)
December Australia New Zealand

10 Haemodialysis Session Length (Hours)
December Australia New Zealand

11 Haemodialysis Duration (Hours per Week)
December Australia New Zealand

12 Percentage of Patients Dialysing Five or More Days per Week
.5 1 1.5 2 2.5 3 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing Five or More Days per Week

13 Percentage of Patients Dialysing Three Days per Week
45 50 55 60 65 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing Three Days per Week Dialysing 4.5 Hours per Session or Longer

14 Percentage of Patients Dialysing >12 Hours per Week
45 50 55 60 65 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing >12 Hours per Week

15 Patient Survival Years
0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years (2726) (3220) (3821) (2975) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia

16 Patient Survival Years
Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years (352) (582) (666) (500)

17 Patient Survival Years
0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years Non-diabetic (9279) Diabetic (3463) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia

18 Patient Survival Years
0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years Non-diabetic (1227) Diabetic (873) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand

19 Patient Survival - Haemodialysis at 90 Days
Censored for Transplant - Australia 1.00 0.80 0.60 Patient Survival 0.40 <40 (1582) 40-59 (4162) 0.20 60-74 (4592) >=75 (2406) 0.00 1 2 3 4 5 Years

20 Patient Survival - Haemodialysis at 90 Days
Censored for Transplant - New Zealand 1.00 0.80 0.60 Patient Survival 0.40 <40 (343) 40-59 (914) 0.20 60-74 (693) >=75 (150) 0.00 1 2 3 4 5 Years

21 Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions
0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years (2726) (3220) (3821) (2975) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions

22 Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions
Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand 1.00 Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions 0.90 0.80 Patient Survival 0.70 0.60 (352) (582) 0.50 (666) (500) 0.40 1 2 3 4 5 Years

23 Haemodialysis Surface Area
Number of Patients Australia

24 Haemodialysis Surface Area
New Zealand Number of Patients

25 Mean Haemoglobin Among Dialysis Patients
100 105 110 115 120 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand PD HD Mean Hb(g/L) Survey Period Mean Haemoglobin Among Dialysis Patients By Survey Period

26 Use of Erythropoietic Agents
30 40 50 60 70 80 90 100 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia Use of Erythropoietic Agents By Survey Period New Zealand Percent Survey Period PD HD

27 Haemoglobin - Australia
December 100 4 9 7 8 7 10 10 Hb (g/L) 11 14 15 16 15 80 23 140+ 21 23 26 25 26 60 Percent 28 27 26 25 40 21 25 20 34 35 27 28 26 28 <110 2005 2006 2007 2005 2006 2007 PD HD

28 Haemoglobin – New Zealand
December 100 6 6 4 6 6 4 9 Hb (g/L) 10 11 12 12 13 80 19 22 140+ 20 22 21 21 60 Percent 31 25 22 25 25 23 40 20 38 39 39 34 36 37 <110 2005 2006 2007 2005 2006 2007 PD HD

29 Haemoglobin - Australia
By Coronary Artery Disease Status December 100 35 35 80 44 Hb (g/L) 46 46 43 60 >120 Percent 30 31 28 29 40 27 27 <110 20 35 34 27 28 27 27 2005 2006 2007 2005 2006 2007 No CAD CAD

30 Haemoglobin – New Zealand
By Coronary Artery Disease Status December 100 32 35 33 36 36 80 40 Hb (g/L) 60 >120 Percent 23 28 26 32 28 26 40 <110 41 20 38 40 36 33 36 2005 2006 2007 2005 2006 2007 No CAD CAD

31 Excludes hospitals with <10 patients
Haemoglobin in Haemodialysis Patients Australia 31 December 2007 140 130 120 Median Hb (g/L) 110 100 Excludes hospitals with <10 patients 90 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

32 Excludes hospitals with <10 patients
Haemoglobin in Haemodialysis Patients New Zealand 31 December 2007 140 130 120 Median Hb (g/L) 110 100 Excludes hospitals with <10 patients 90 1 2 3 4 5 6 7 8 9 Caring Hospital

33 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Haemodialysis Patients with Hb g/L Australia 31 December 2007

34 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Haemodialysis Patients with Hb g/L New Zealand 31 December 2007

35 Excludes hospitals with <10 patients
90 100 110 120 130 140 Median Hb (g/L) 5 10 15 20 25 30 35 Caring Hospital Haemoglobin in Peritoneal Dialysis Patients Australia 31 December 2007

36 Excludes hospitals with <10 patients
90 100 110 120 130 140 Median Hb (g/L) 1 2 3 4 5 6 7 8 9 10 Caring Hospital Haemoglobin in Peritoneal Dialysis Patients New Zealand 31 December 2007

37 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 % Peritoneal Dialysis Patients with Hb g/L Australia 31 December 2007 35 Caring Hospital

38 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Peritoneal Dialysis Patients with Hb g/L New Zealand 31 December 2007

39 Ferritin - Australia December 100 15 14 11 15 17 18 mcg/L 16 80 18 19 23 800+ 23 21 60 Percent 39 35 37 38 38 38 40 16 19 18 20 12 11 12 <100 16 13 15 12 11 11 2005 2006 2007 2005 2006 2007 PD HD

40 Ferritin - New Zealand December 100 12 11 10 15 15 mcg/L 20 14 18 80 18 21 22 800+ 22 60 42 Percent 39 40 36 36 31 40 18 21 17 15 14 12 20 <100 14 12 14 13 13 15 2005 2006 2007 2005 2006 2007 PD HD

41 Transferrin Saturation - Australia
December 100 13 12 13 14 14 15 Tsat (%) 80 20 20 21 20 19 19 40+ 60 Percent 30-39 41 38 38 37 41 39 40 20-29 20 <20 26 27 27 29 29 30 2005 2006 2007 2005 2006 2007 PD HD

42 Transferrin Saturation - New Zealand
December 100 16 14 13 15 13 15 Tsat (%) 80 19 22 22 19 21 19 40+ 60 Percent 30-39 37 36 33 39 38 38 40 20-29 20 <20 29 30 33 26 26 26 2005 2006 2007 2005 2006 2007 PD HD

43 Excludes hospitals with <10 patients
% Haemodialysis Patients with Ferritin mcg/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

44 Excludes hospitals with <10 patients
% Haemodialysis Patients with Ferritin mcg/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

45 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Ferritin mcg/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

46 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Ferritin mcg/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

47 Excludes hospitals with <10 patients
% Haemodialysis Patients with TSat >20% Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

48 Excludes hospitals with <10 patients
% Haemodialysis Patients with TSat >20% New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

49 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with TSat >20% Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

50 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with TSat >20% New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

51 Serum Calcium - Australia
December 100 8 6 8 Calcium 12 11 9 (mmol/L) 21 22 80 25 27 28 29 >=2.6 60 38 Percent 37 41 40 36 37 40 22 26 20 18 19 20 17 <2.0 11 7 9 5 5 6 2005 2006 2007 2005 2006 2007 PD HD

52 Serum Calcium - New Zealand
December 100 Calcium 12 10 11 14 14 20 (mmol/L) 80 28 25 30 35 33 >=2.6 36 60 Percent 36 37 34 40 31 33 27 20 22 19 20 15 13 16 <2.0 5 5 5 4 6 4 2005 2006 2007 2005 2006 2007 PD HD

53 Excludes hospitals with <10 patients
% Haemodialysis Patients with Calcium mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

54 Excludes hospitals with <10 patients
% Haemodialysis Patients with Calcium mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

55 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Calcium mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

56 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Calcium mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

57 Serum Phosphate - Australia
December 100 Phosphate 35 38 37 36 39 38 (mmol/L) 80 >=1.8 60 15 13 15 14 14 Percent 15 17 15 16 40 18 15 16 20 33 34 35 29 30 32 <1.4 2005 2006 2007 2005 2006 2007 PD HD

58 Serum Phosphate - New Zealand
December 100 Phosphate 40 40 (mmol/L) 80 44 48 54 54 >=1.8 60 Percent 14 16 15 16 40 13 13 20 15 17 12 11 13 20 29 <1.4 24 26 25 21 21 2005 2006 2007 2005 2006 2007 PD HD

59 Excludes hospitals with <10 patients
% Haemodialysis Patients with Phosphate mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

60 Excludes hospitals with <10 patients
% Haemodialysis Patients with Phosphate mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

61 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Phosphate mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

62 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Phosphate mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

63 Calcium Phosphate Product - Australia
December 100 Ca X P 18 16 16 20 20 17 (mmol2/L2) 80 9 10 11 9 11 10 >=5.0 13 14 13 12 13 13 60 Percent 17 15 16 17 14 15 40 43 43 46 42 43 42 20 <3.5 2005 2006 2007 2005 2006 2007 PD HD

64 Calcium Phosphate Product - New Zealand
December 100 Ca X P 20 18 24 (mmol2/L2) 30 35 33 80 11 12 11 >=5.0 14 11 14 13 60 12 12 Percent 14 16 17 14 13 18 40 14 13 13 20 39 40 35 32 27 28 <3.5 2005 2006 2007 2005 2006 2007 PD HD

65 Excludes hospitals with <10 patients
% Haemodialysis Patients with Ca-P Product <4.0 mmol2/L2 Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

66 Excludes hospitals with <10 patients
% Haemodialysis Patients with Ca-P Product <4.0 mmol2/L2 New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

67 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Ca-P Product <4.0 mmol2/L2 Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

68 Excludes hospitals with <10 patients
% Peritoneal Dialysis Patients with Ca-P Product <4.0 mmol2/L2 New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

69 HD Three Sessions per Week
Urea Reduction Ratio HD Three Sessions per Week 100 URR (%) 12 11 12 22 24 28 13 80 16 17 80-100 75-79 27 26 23 22 60 27 25 Percent 70-74 20 40 26 22 26 21 65-69 25 18 16 60-64 20 15 14 14 12 6 6 12 14 5 12 <60 4 3 3 2005 2006 2007 2005 2006 2007 Australia New Zealand

70 Urea Reduction Ratio Related to Type of Access
HD Three Sessions per Week December 2007 100 URR (%) 12 10 21 21 26 12 80-100 80 43 18 20 19 19 75-79 60 28 22 Percent 70-74 22 26 22 26 40 23 65-69 27 18 13 19 17 60-64 20 15 11 12 11 10 17 5 10 9 <60 8 3 3 1 AVF AVG CVC AVF AVG CVC Australia New Zealand

71 Excludes hospitals with <10 patients
60 70 80 90 100 Median URR (%) 5 10 15 20 25 30 35 40 45 50 55 Caring Hospital URR (%) – Haemodialysis Patients (Three Sessions per Week) Australia 31 December 2007

72 Excludes hospitals with <10 patients
60 70 80 90 100 Median URR (%) 1 2 3 4 5 6 7 Caring Hospital URR (%) - Haemodialysis Patients (Three Sessions per Week) New Zealand 31 December 2007

73 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Haemodialysis Patients with URR >70% (Three Sessions per Week) Australia 31 December 2007

74 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 Caring Hospital % Haemodialysis Patients with URR >70% (Three Sessions per Week) New Zealand 31 December 2007

75 Vascular Access - Initial RRT
Haemodialysis at Initial Modality AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 25 25 25 22 80 40 46 45 50 60 36 37 37 37 Percent 28 27 40 3 3 3 30 2 27 1 1 2 2 20 36 35 36 37 31 27 22 23 2004 2005 2006 2007 2004 2005 2006 2007 Australia New Zealand

76 Vascular Access - Initial RRT
24 2 44 29 35 37 25 38 4 21 3 39 20 8 54 28 1 31 40 23 47 13 7 30 50 60 80 100 Percent Australia New Zealand <25 25-54 55-74 >=75 Vascular Access - Initial RRT By Age Group 2007 AVF AVG Tunnel Catheter Non-Tunnel Catheter

77 Vascular Access - Initial RRT
38 3 35 25 2 36 24 37 23 41 21 34 26 32 40 27 20 60 80 100 Percent Non Diabetic Diabetic 2004 2005 2006 2007 Vascular Access - Initial RRT By Diabetic Status - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter

78 Vascular Access - Initial RRT
37 26 32 2 41 21 25 52 3 28 44 24 30 50 22 1 47 20 46 40 60 80 100 Percent Non Diabetic Diabetic 2004 2005 2006 2007 Vascular Access - Initial RRT By Diabetic Status - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter

79 Vascular Access - Initial RRT
By Gender - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 25 22 23 23 24 23 28 28 80 60 40 35 36 35 36 39 Percent 37 39 1 40 1 2 2 4 5 5 3 20 40 39 39 39 33 29 29 32 2004 2005 2006 2007 2004 2005 2006 2007 Female Male

80 Vascular Access - Initial RRT
By Gender - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 37 80 47 46 45 43 50 47 49 60 Percent 26 24 29 40 32 32 31 1 26 30 1 1 1 2 1 20 2 4 37 30 24 26 19 20 18 17 2004 2005 2006 2007 2004 2005 2006 2007 Female Male

81 Vascular Access - Initial RRT
By Referral Time - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 18 19 18 16 80 41 42 42 39 30 31 33 31 60 Percent 3 3 4 3 40 47 49 51 54 49 45 47 48 20 2 1 1 10 9 6 7 2004 2005 2006 2007 2004 2005 2006 2007 Early Late

82 Vascular Access - Initial RRT By Referral - New Zealand
AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 34 36 39 37 80 56 65 71 74 60 Percent 25 27 30 31 40 2 1 2 3 35 26 20 39 36 30 29 28 21 1 9 1 8 1 4 2004 2005 2006 2007 2004 2005 2006 2007 Early Late

83 Excludes hospitals with <10 patients
% New HD Patients Starting with AVF/AVG Australia 1 Jan Dec 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 Caring Hospital

84 Excludes hospitals with <10 patients
% New HD Patients Starting with AVF/AVG New Zealand 1 Jan Dec 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 Caring Hospital

85 Prevalent Haemodialysis Access
AVF AVG Tunnel Catheter Non-Tunnel Catheter 1 1 1 2 3 2 1 100 10 11 11 13 25 22 23 24 14 12 11 11 80 6 5 6 7 60 Percent 40 75 76 76 76 69 70 70 66 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand

86 Prevalent Haemodialysis Access
By Age Group - December 2007 AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 1 1 1 1 2 12 13 15 18 19 28 26 8 31 2 12 80 12 6 5 5 6 Percent 60 40 79 79 75 73 75 67 67 61 20 <25 25-54 55-74 >=75 <25 25-54 55-74 >=75 Australia New Zealand

87 Prevalent Haemodialysis Access By Diabetic Status - Australia
AVF AVG Tunnel Catheter Non-Tunnel Catheter 1 1 1 1 1 1 1 100 9 9 10 12 13 13 14 15 15 13 13 11 11 10 80 13 10 60 Percent 40 75 77 77 77 73 75 76 74 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Non Diabetic Diabetic

88 Prevalent Haemodialysis Access By Diabetic Status - New Zealand
AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 2 3 2 1 3 3 2 1 22 20 22 22 25 25 27 28 80 7 6 5 6 4 6 5 6 60 Percent 40 68 71 71 72 70 67 63 66 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Non Diabetic Diabetic

89 Prevalent Haemodialysis Access
By Gender - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 1 1 1 1 1 1 1 9 9 10 13 11 14 14 17 10 9 8 8 80 20 18 16 15 60 Percent 82 81 81 40 80 66 67 69 68 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Female Male

90 Prevalent Haemodialysis Access
By Gender - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 2 4 2 1 3 2 2 1 20 18 18 19 34 29 31 32 80 3 2 3 4 11 8 9 60 11 Percent 40 78 74 77 77 56 58 58 53 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Female Male

91 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Prevalent HD Patients Dialysing with AVF/AVG Australia 31 December 2007

92 Excludes hospitals with <10 patients
10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Prevalent HD Patients Dialysing with AVF/AVG New Zealand 31 December 2007

Download ppt "Stock and Flow of Haemodialysis Patients Australia"

Similar presentations

UK Renal Registry 16th Annual Report Figure 14.1. Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
ESRD Registry Committee, Korean Society of Nephrology*

ESRD Registry Committee, Korean Society of Nephrology*
UK Renal Registry 17th Annual Report Figure 10.1. Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.

UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.

Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients 2006 - 2010 20062007200820092010 Australia Patients new.

HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.

UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 16th Annual Report Figure 10.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.

UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.

UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.

© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate

UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.

Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.

Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.

Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.

CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.

UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.

UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
© ANZDATA Registry Method and Location of Dialysis 1990-1998 1655 (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.

© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.

Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.

Similar presentations

Ads by Google